Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator– and Placebo-Controlled Study

  1. Blanco, F.J.
  2. Möricke, R.
  3. Dokoupilova, E.
  4. Codding, C.
  5. Neal, J.
  6. Andersson, M.
  7. Rohrer, S.
  8. Richards, H.
Journal:
Arthritis and Rheumatology

ISSN: 2326-5205 2326-5191

Year of publication: 2017

Volume: 69

Issue: 6

Pages: 1144-1153

Type: Article

DOI: 10.1002/ART.40070 GOOGLE SCHOLAR

Sustainable development goals